Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Persistence of neutralizing antibodies a year after SARS‐CoV‐2 infection in humans
Anu Haveri, Nina Ekström, Anna Solastie, et al.
European Journal of Immunology (2021) Vol. 51, Iss. 12, pp. 3202-3213
Open Access | Times Cited: 90

Showing 1-25 of 90 citing articles:

Impact of the Delta variant on vaccine efficacy and response strategies
Lianlian Bian, Qiushuang Gao, Fan Gao, et al.
Expert Review of Vaccines (2021) Vol. 20, Iss. 10, pp. 1201-1209
Open Access | Times Cited: 215
A systematic review of Vaccine Breakthrough Infections by SARS-CoV-2 Delta Variant
Mengxin Zhang, Ying Liang, Dongsheng Yu, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 2, pp. 889-900
Open Access | Times Cited: 60
Comparative analysis of COVID-19 vaccine responses and third booster dose-induced neutralizing antibodies against Delta and Omicron variants
Milja Belik, Pinja Jalkanen, Rickard Lundberg, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 55
Long-term Immune Response to SARS-CoV-2 Infection Among Children and Adults After Mild Infection
Costanza Di Chiara, Anna Cantarutti, Paola Costenaro, et al.
JAMA Network Open (2022) Vol. 5, Iss. 7, pp. e2221616-e2221616
Open Access | Times Cited: 52
Long-Lasting T Cell Responses in BNT162b2 COVID-19 mRNA Vaccinees and COVID-19 Convalescent Patients
Antti Hurme, Pinja Jalkanen, Jemna Heroum, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 51
COVID‐19 and plasma cells: Is there long‐lived protection?*
Doan C. Nguyen, Pedro A. Lamothe, Matthew C. Woodruff, et al.
Immunological Reviews (2022) Vol. 309, Iss. 1, pp. 40-63
Open Access | Times Cited: 41
Neutralizing antibodies to SARS‐CoV‐2 Omicron variant after third mRNA vaccination in health care workers and elderly subjects
Anu Haveri, Anna Solastie, Nina Ekström, et al.
European Journal of Immunology (2022) Vol. 52, Iss. 5, pp. 816-824
Open Access | Times Cited: 39
SARS-CoV-2—The Role of Natural Immunity: A Narrative Review
Sara Diani, Erika Leonardi, Attilio Cavezzi, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 21, pp. 6272-6272
Open Access | Times Cited: 33
Immune correlates of protection for SARS-CoV-2, Ebola and Nipah virus infection
Beatriz Escudero-Pérez, Philip Lawrence, Javier Castillo‐Olivares
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
Plasma biomarkers for systemic inflammation in COVID‐19 survivors
Juan Zhao, Madison Schank, Ling Wang, et al.
PROTEOMICS - CLINICAL APPLICATIONS (2022) Vol. 16, Iss. 5
Open Access | Times Cited: 26
Clinical course impacts early kinetics,magnitude, and amplitude of SARS-CoV-2 neutralizing antibodies beyond 1 year after infection
Edwards Pradenas, Benjamin Trinité, Víctor Urrea, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 2, pp. 100523-100523
Open Access | Times Cited: 23
Research progress on vaccine efficacy against SARS-CoV-2 variants of concern
Lianlian Bian, Jianyang Liu, Fan Gao, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 23
Genomic diversity of SARS‐CoV‐2 in Pakistan during the fourth wave of pandemic
Massab Umair, Aamer Ikram, Zaira Rehman, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 10, pp. 4869-4877
Open Access | Times Cited: 19
Persistence of SARS-CoV-2 neutralizing antibodies longer than 13 months in naturally infected, captive white-tailed deer ( Odocoileus virginianus ), Texas
Sarah A. Hamer, Chase M. Nunez, Christopher M. Roundy, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 2112-2115
Open Access | Times Cited: 18
Changes in SARS-CoV-2 seroprevalence and population immunity in Finland, 2020–2022
Anna Solastie, Tuomo Nieminen, Nina Ekström, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 11
Performance Analysis of Serodiagnostic Tests to Characterize the Incline and Decline of the Individual Humoral Immune Response in COVID-19 Patients: Impact on Diagnostic Management
Ronald von Possel, Babett Menge, Christina Deschermeier, et al.
Viruses (2024) Vol. 16, Iss. 1, pp. 91-91
Open Access | Times Cited: 3
Hybrid Immunity Improves the Immune Response after the Fourth COVID-19 Vaccine Dose in Individuals with Medical Conditions Predisposing to Severe COVID-19
Nina Ekström, Tuija M. Leino, Aapo Juutinen, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 247-247
Open Access | Times Cited: 3
A Highly Sensitive and Specific SARS-CoV-2 Spike- and Nucleoprotein-Based Fluorescent Multiplex Immunoassay (FMIA) to Measure IgG, IgA, and IgM Class Antibodies
Anna Solastie, Camilla Virta, Anu Haveri, et al.
Microbiology Spectrum (2021) Vol. 9, Iss. 3
Open Access | Times Cited: 23
SARS-CoV-2 infection-induced immunity reduces rates of reinfection and hospitalization caused by the Delta or Omicron variants
Marc-Antoine de La Vega, Efstathia Polychronopoulou, Ara XIII, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 9
“Long COVID” results after hospitalization for SARS-CoV-2 infection
Marta Rigoni, Emanuele Torri, Giandomenico Nollo, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 15
Major Update 2: Antibody Response and Risk for Reinfection After SARS-CoV-2 Infection—Final Update of a Living, Rapid Review
Haley K Holmer, Katherine Mackey, Celia Fiordalisi, et al.
Annals of Internal Medicine (2022) Vol. 176, Iss. 1, pp. 85-91
Open Access | Times Cited: 15
Dynamics of SARS-CoV-2 seroassay sensitivity: a systematic review and modelling study
Nana Owusu‐Boaitey, Timothy Russell, Gideon Meyerowitz‐Katz, et al.
Eurosurveillance (2023) Vol. 28, Iss. 21
Open Access | Times Cited: 8
Vaccine-Induced Antibody Responses against SARS-CoV-2 Variants-Of-Concern Six Months after the BNT162b2 COVID-19 mRNA Vaccination
Pinja Jalkanen, Pekka Kolehmainen, Anu Haveri, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 2
Open Access | Times Cited: 13
SARS-CoV-2 - The Role of Natural Immunity: A Narrative Review
Sara Diani, Erika Leonardi, Attilio Cavezzi, et al.
(2022)
Open Access | Times Cited: 13
Associations Between Symptoms, Donor Characteristics and IgG Antibody Response in 2082 COVID-19 Convalescent Plasma Donors
Marieke Vinkenoog, Maurice Steenhuis, Anja ten Brinke, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top